https://azd6482inhibitor.com/i....mproving-tradition-c
The mortality rates for intense myeloid leukemia are particularly large, necessitating the look for unique chemotherapeutic candidates. Herein, we investigated the anticancer potential of a new artificial compound, 2-ethyl-3-methyliden-1-tosyl-2,3-dihydroquinolin-4-(1H)-one (AJ-374) against myeloid leukemia HL-60 cell range. This analog ended up being chosen through the little library of synthetic dihydroquinolinones on such basis as its powerful antiproliferative activity against HL-60
Like
Comment
Share
